150 related articles for article (PubMed ID: 22398969)
21. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
22. Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients.
Joly P; Gagnieu MC; Bardel C; Francina A; Pondarre C; Martin C
Am J Hematol; 2012 May; 87(5):534-6. PubMed ID: 22430884
[TBL] [Abstract][Full Text] [Related]
23. Environmental and genetic factors associated with morphine response in the postoperative period.
Coulbault L; Beaussier M; Verstuyft C; Weickmans H; Dubert L; Trégouet D; Descot C; Parc Y; Lienhart A; Jaillon P; Becquemont L
Clin Pharmacol Ther; 2006 Apr; 79(4):316-24. PubMed ID: 16580900
[TBL] [Abstract][Full Text] [Related]
24. Is maternal opioid use hazardous to breast-fed infants?
Hendrickson RG; McKeown NJ
Clin Toxicol (Phila); 2012 Jan; 50(1):1-14. PubMed ID: 22148986
[TBL] [Abstract][Full Text] [Related]
25. The Implausibility of Neonatal Opioid Toxicity from Breastfeeding.
Zipursky J; Juurlink DN
Clin Pharmacol Ther; 2020 Nov; 108(5):964-970. PubMed ID: 32378749
[TBL] [Abstract][Full Text] [Related]
26. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer.
Susce MT; Murray-Carmichael E; de Leon J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1356-8. PubMed ID: 16631290
[TBL] [Abstract][Full Text] [Related]
27. Pain and genetics.
Fernandez Robles CR; Degnan M; Candiotti KA
Curr Opin Anaesthesiol; 2012 Aug; 25(4):444-9. PubMed ID: 22732422
[TBL] [Abstract][Full Text] [Related]
28. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
29. A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.
Leon Jd; Susce MT; Pan RM; Wedlund PJ; Orrego ML; Diaz FJ
Pharmacopsychiatry; 2007 May; 40(3):93-102. PubMed ID: 17541883
[TBL] [Abstract][Full Text] [Related]
30. Safety issues of maternal drug therapy during breastfeeding.
Berlin CM; Paul IM; Vesell ES
Clin Pharmacol Ther; 2009 Jan; 85(1):20-2. PubMed ID: 19092767
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
[TBL] [Abstract][Full Text] [Related]
32. Codeine-related deaths: The role of pharmacogenetics and drug interactions.
Lam J; Woodall KL; Solbeck P; Ross CJ; Carleton BC; Hayden MR; Koren G; Madadi P
Forensic Sci Int; 2014 Jun; 239():50-6. PubMed ID: 24747667
[TBL] [Abstract][Full Text] [Related]
33. CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.
Gex-Fabry M; Eap CB; Oneda B; Gervasoni N; Aubry JM; Bondolfi G; Bertschy G
Ther Drug Monit; 2008 Aug; 30(4):474-82. PubMed ID: 18641553
[TBL] [Abstract][Full Text] [Related]
34. Global genetic variation of select opiate metabolism genes in self-reported healthy individuals.
Wendt FR; Pathak G; Sajantila A; Chakraborty R; Budowle B
Pharmacogenomics J; 2018 Apr; 18(2):281-294. PubMed ID: 28398354
[TBL] [Abstract][Full Text] [Related]
35. Is there a role for therapeutic drug monitoring with codeine?
Kelly LE; Madadi P
Ther Drug Monit; 2012 Jun; 34(3):249-56. PubMed ID: 22569351
[TBL] [Abstract][Full Text] [Related]
36. Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Lötsch J; Rohrbacher M; Schmidt H; Doehring A; Brockmöller J; Geisslinger G
Pain; 2009 Jul; 144(1-2):119-24. PubMed ID: 19395173
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
38. Genetic variability and clinical efficacy of morphine.
Klepstad P; Dale O; Skorpen F; Borchgrevink PC; Kaasa S
Acta Anaesthesiol Scand; 2005 Aug; 49(7):902-8. PubMed ID: 16045647
[TBL] [Abstract][Full Text] [Related]
39. Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach.
Escorial M; Muriel J; Agulló L; Zandonai T; Margarit C; Morales D; Peiró AM
Minerva Anestesiol; 2024 May; 90(5):386-396. PubMed ID: 38619184
[TBL] [Abstract][Full Text] [Related]
40. Genetic factors in pain and its treatment.
Stamer UM; Stüber F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]